Corpus Intelligence IC Memo — CHILDRENS HOSPITAL OF WI-FOX VALLEY 2026-04-26 09:05 UTC
IC Memo — CHILDRENS HOSPITAL OF WI-FOX VALLEY
Investment Committee Memorandum | WI | 42 beds | Grade D | EBITDA uplift $2.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

CHILDRENS HOSPITAL OF WI-FOX VALLEY

CCN 523302 | WINNEBAGO, WI | 42 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

CHILDRENS HOSPITAL OF WI-FOX VALLEY is a 42-bed community hospital in WINNEBAGO, WI with $30.8M in net patient revenue and a -19.7% operating margin. The hospital serves a payer mix of 0.0% Medicare, 15.7% Medicaid, and 84.3% commercial.

Thesis: Turnaround. Our ML models identify $2.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -19.7% to -12.3% (+736bps).

Net Revenue HCRIS$30.8M
Current EBITDA COMPUTED$-6.1M
Operating Margin COMPUTED-19.7%
Occupancy HCRIS35.5%
Revenue / Bed COMPUTED$734K
Net-to-Gross HCRIS73.5%
Distress Probability MLnan%

2. Market Context & Competitive Position

150
WI Hospitals
0.4%
State Median Margin
90
Comparable Hospitals

WI has 150 Medicare-certified hospitals with a median operating margin of 0.4%. The target's margin of -19.7% places it below the state median. Among 90 size-comparable peers (21-84 beds), the median margin is 2.0%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (21-84), prioritizing same-state peers. 90 hospitals in the comp set.

HospitalStateBedsRevenueMargin
CHILDRENS HOSPITAL OF WI-FOX V (Target)WI42$30.8M-19.7%
MERCY WALWORTH HOSPITALWI25$616.4M4.4%
ST. JOSEPHS COMM. HOSPT.WI70$436.8M66.1%
ST. AGNES HOSPITALWI77$275.9M-3.0%
AURORA MEDICAL CENTER OF OSHKOWI79$222.3M17.9%
MARSHFIELD MEDICAL CENTER-EAU WI56$214.6M-21.8%
ASPIRUS STEVENS POINT HOSPITALWI82$201.4M28.9%
MONROE CLINICWI58$195.3M-4.4%
ASPIRUS RIVERVIEW HOSPITAL & CWI44$161.3M13.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$647K+210bp18mo
Cost to Collect4.5%2.5%$616K+200bp12mo
Denial Rate Reduction12.0%6.5%$610K+198bp12mo
A/R Days Reduction5200.0%3800.0%$375K+122bp9mo
Clean Claim Rate88.0%96.0%$20K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$647K
Cost to Collect
$616K
Denial Rate Reduction
$610K
A/R Days Reduction
$375K
Clean Claim Rate
$20K
Total EBITDA Uplift$2.3M
Current EBITDA$-6.1M
+ RCM Uplift+$2.3M
Pro Forma EBITDA$-3.8M
Current Margin-19.7%
Pro Forma Margin-12.3%
WC Released (1x)$1.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-9.3M$-17.3M0.00x-100.0%
Base (11x exit)10.0x11.0x$-9.3M$-22.1M0.00x-100.0%
Bull Case9.0x11.0x$-8.4M$-17.6M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-8.4M$-21.7M0.00x-100.0%
Bear Case11.0x10.0x$-10.3M$-25.6M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-10.3M$-31.5M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 90 hospitals with 21-84 beds
  • Same-state prioritization (n=91)
  • Comp margins: P25=-8.0% / P50=2.0% / P75=8.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.